124 related articles for article (PubMed ID: 8102809)
21. Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment.
Feltelius N; Hällgren R; Venge P
Ann Rheum Dis; 1987 May; 46(5):403-7. PubMed ID: 2884933
[TBL] [Abstract][Full Text] [Related]
22. Sulfasalazine and ankylosing spondylitis.
Amor B; Kahan A; Dougados M; Delrieu F
Ann Intern Med; 1984 Dec; 101(6):878. PubMed ID: 6149718
[No Abstract] [Full Text] [Related]
23. Should tests for proteinuria be included in the monitoring schedule of sulphasalazine?
Helliwell PS
Br J Rheumatol; 1995 Aug; 34(8):790-1. PubMed ID: 7551669
[TBL] [Abstract][Full Text] [Related]
24. Sulphasalazine-induced aseptic meningitis with facial and nuchal edema in a patient with spondyloarthritis.
Tay SH; Lateef A; Cheung PP
Int J Rheum Dis; 2012 Aug; 15(4):e71-2. PubMed ID: 22898230
[No Abstract] [Full Text] [Related]
25. Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.
Feltelius N; Hällgren R
Ann Rheum Dis; 1988 Jan; 47(1):10-4. PubMed ID: 2894204
[TBL] [Abstract][Full Text] [Related]
26. Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia.
Damjanov N; Shehhi WA; Huang F; Kotak S; Burgos-Vargas R; Shirazy K; Bananis E; Szumski A; Llamado LJ; Mahgoub E
Rheumatol Int; 2016 May; 36(5):643-51. PubMed ID: 26968844
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
van der Heijde D; Braun J; Dougados M; Sieper J; Pedersen R; Szumski A; Koenig AS
Rheumatology (Oxford); 2012 Oct; 51(10):1894-905. PubMed ID: 22772319
[TBL] [Abstract][Full Text] [Related]
28. Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial.
Nissilä M; Lehtinen K; Leirisalo-Repo M; Luukkainen R; Mutru O; Yli-Kerttula U
Arthritis Rheum; 1988 Sep; 31(9):1111-6. PubMed ID: 2901839
[TBL] [Abstract][Full Text] [Related]
29. [Sulfasalazine in rheumatology].
Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].
Suschke HJ
Monatsschr Kinderheilkd; 1992 Sep; 140(9):658-60. PubMed ID: 1359405
[TBL] [Abstract][Full Text] [Related]
31. Late onset hypersensitivity to sulfasalazine in a patient with ankylosing spondylitis.
Paul RH; Toder JS; Cohen RA
Arthritis Care Res; 1999 Dec; 12(6):435-6. PubMed ID: 11081015
[No Abstract] [Full Text] [Related]
32. Sulfasalazine for ankylosing spondylitis.
Chen J; Liu C
Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
[TBL] [Abstract][Full Text] [Related]
33. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.
Clegg DO; Reda DJ; Weisman MH; Blackburn WD; Cush JJ; Cannon GW; Mahowald ML; Schumacher HR; Taylor T; Budiman-Mak E; Cohen MR; Vasey FB; Luggen ME; Mejias E; Silverman SL; Makkena R; Alepa FP; Buxbaum J; Haakenson CM; Ward RH; Manaster BJ; Anderson RJ; Ward JR; Henderson WG
Arthritis Rheum; 1996 Dec; 39(12):2004-12. PubMed ID: 8961905
[TBL] [Abstract][Full Text] [Related]
34. Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.
Huang JL; Hung IJ; Hsieh KH
Asian Pac J Allergy Immunol; 1997 Jun; 15(2):71-5. PubMed ID: 9346269
[TBL] [Abstract][Full Text] [Related]
35. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis: comment on the article by Clegg et al.
Helliwell PS
Arthritis Rheum; 1997 Oct; 40(10):1911-2. PubMed ID: 9336437
[No Abstract] [Full Text] [Related]
36. Sulfasalazine might reduce risk of cardiovascular diseases in patients with ankylosing spondylitis: A nationwide population-based retrospective cohort study.
Tam HW; Yeo KJ; Leong PY; Chen CH; Li YC; Ma CM; Wang YH; Chiou JY; Wei JC
Int J Rheum Dis; 2017 Mar; 20(3):363-370. PubMed ID: 27943609
[TBL] [Abstract][Full Text] [Related]
37. Hyoscine skin patches for drooling dilate pupils and impair accommodation: spectacle correction for photophobia and blurred vision may be warranted.
Saeed M; Henderson G; Dutton GN
Dev Med Child Neurol; 2007 Jun; 49(6):426-8. PubMed ID: 17518927
[TBL] [Abstract][Full Text] [Related]
38. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
[TBL] [Abstract][Full Text] [Related]
39. Sulfasalazine-induced aseptic meningitis with positive rechallenge: a case report and review of the literature.
Salouage I; El Aïdli S; Cherif F; Kastalli S; Zaiem A; Daghfous R
Therapie; 2013; 68(6):423-6. PubMed ID: 24356191
[No Abstract] [Full Text] [Related]
40. [Experience in the use of salazopyrine EN in patients with spondylarthritis ankylopoietica and rheumatoid arthritis].
Somhegyi A; Gömör B
Orv Hetil; 1988 Sep; 129(36):1917-21. PubMed ID: 2902550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
